Form D Report: Saptalis Pharmaceuticals $6.50 million Financing. Polireddy Dondeti Submitted Nov 8 SEC form

Pharmaceuticals Saptalis Pharmaceuticals, Llc - Polireddy Dondeti

Saptalis Pharmaceuticals Financing

Saptalis Pharmaceuticals, Llc, Limited Liability Company just had published form D regarding $6.50 million equity financing. This is a new filing. Saptalis Pharmaceuticals was able to fundraise $6.50 million. That is 100.00% of the offering. The total private offering amount was $6.50 million. The private financing document was filed on 2016-11-08. The reason for the financing was: unspecified.

Saptalis Pharmaceuticals is based in New York. The company’s business is Pharmaceuticals. The D form was signed by Polireddy Dondeti President and CEO. The company was incorporated in 2015. The filler’s address is: 45 Davids Drive, Hauppauge, Ny, New York, 11788. Polireddy Dondeti is the related person in the form and it has address: 45 Davids Drive, Hauppauge, Ny, New York, 11788. Link to Saptalis Pharmaceuticals Filing: 000090901216000603.

Analysis of Saptalis Pharmaceuticals Offering

On average, firms in the Pharmaceuticals sector, sell 60.90% of the total offering size. Saptalis Pharmaceuticals sold 100.00% of the offering. Could this mean that the trust in Saptalis Pharmaceuticals is high? The average offering size for companies in the Pharmaceuticals industry is $556,000. The total amount raised is 1,069.06% bigger than the average for companies in the Pharmaceuticals sector. The minimum investment for this financing is set at $0. If you know more about the reasons for the fundraising, please comment below.

What is Form D? What It Is Used For

Form D disclosures could be used to track and understand better your competitors. The information in Form D is usually highly confidential for ventures and startups and they don’t like revealing it. This is because it reveals amount raised or planned to be raised as well as reasons for the financing. This could help competitors. Entrepreneurs usually want to keep their financing a ‘secret’ so they can stay in stealth mode for longer.

Why Fundraising Reporting Is Good For Saptalis Pharmaceuticals Also

The Form D signed by Polireddy Dondeti might help Saptalis Pharmaceuticals, Llc’s sector. First, it helps potential customers feel more safe to deal with a firm that is well financed. The odds are higher that it will stay in the business. Second, this could attract other investors such as venture-capital firms, funds and angels. Third, positive PR effects could even bring leasing firms and venture lenders.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Related posts

Leave a Comment